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Background: The role of microRNAs (miRs) in the development of various cardiovascular diseases was recently high-
lighted in several studies. However, the biological role of miRs in the pathogenesis of abdominal aortic aneurysms (AAAs)
is still not well deﬁned. The present study aims to identify and characterize miR expression in the aortic explant cultures of
AAA patients.
Methods: A new microarray platform (miChip) using locked nucleic acid-modiﬁed capture probes with increased sensitivity
and speciﬁcity was employed to detect the miR expression proﬁle in human vascular smooth muscle cell cultures from
AAA surgical samples. The array data were further validated by real-time quantitative reverse transcription polymerase
chain reaction (qPCR) experiments with additional AAA and control aorta samples. Potential target genes of the
differentially expressed miRs were predicted by bioinformatics analysis. Some of the results were conﬁrmed by enzyme
immunosorbent assay and Western blot analysis.
Results: Total RNA extracted from the explant of six AAAs and six normal aortas exhibited notably different miR proﬁles.
A twofold difference of miR-516a-5p and miR-1260 was expressed in AAAs compared with normal aortic cultures
(P < .05). The expression of miR-516a-5p was more than three times higher in AAAs, and miR-1260 expression was
almost four times lower, as validated by qPCR. Additional qPCR performing on an extra 10 AAAs and 10 control aortas
showed similar results. The expression of three predicted targetsdsecretory interleukin-3, vascular endothelial growth
factor A, and collagen type 1, alpha 1 proteinsdwas signiﬁcantly elevated in aneurysmal cultures compared with normal
aortic cultures (P < .05).
Conclusions: This miRmicroarray study displayed an altered expression of miR-516a-5p andmiR-1260 in AAAs compared
with control aortas. Functional annotations of the two miRs via bioinformatics approaches revealed that both are highly
involved in some predeﬁnedmechanisms of AAA formation. Three of their target genes were also upregulated in AAAs. The
results may be critical to elucidate the functional role of miRs in diseased aorta. (J Vasc Surg 2014;59:202-9.)
Clinical Relevance: MicroRNAs are newly found pathologic factors for many cardiovascular diseases. However, its
involvement in abdominal aortic aneurysms (AAAs) is still a mystery. The novel ﬁndings of two differential miRs asso-
ciated with their target protein expression in aneurysmal tissues may be important in delineating partly the pathophys-
iology of AAAs. The manipulating of the miRs in AAAs may then become a new therapeutic concept in the future.Abdominal aortic aneurysm (AAA) is a common di-
lating disorder of the aorta and a major cause of death
due to rupture.1 The majority of previous studies on
human tissue have focused on some predeﬁned pathways
such as chronic inﬂammatory condition with a proteolytic
imbalance, but the complex regulation of gene expression
and translation involved in driving aneurysmal formation
and growth remain unresolved. A group of microRNAs
(miRs) have recently emerged as new study target for
precise gene regulation.2 They are highly conserved, 21
to 23 nucleotides in length, and typically encoded withinthe Division of Vascular Surgery, Department of Surgery, The
niversity of Hong Kong.
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://dx.doi.org/10.1016/j.jvs.2013.02.244introns, which regulate gene expression in animals at the
post-translational level. By annealing to the 3’ untranslated
region (UTR) in the target messenger RNAs, the miRs
mostly mediate translational repression or degradation of
the mRNAs, resulting in downregulation of the protein
level. In addition, miRs are also able to stimulate gene
expression.3 More than 1000 miRs have been identiﬁed
in the human genome (miRBase v. 16.0). In fact, bio-
informatic analysis predicts that each miR regulates
hundreds of targets, which suggests that miRs may play
a role in almost every biological pathway, including devel-
opmental timing and patterning, differentiation, prolifera-
tion morphogenesis, and apoptosis.3 In conclusion, miR
represents a new layer of precise regulation for sequence-
speciﬁc gene expression. The importance of the miR regu-
latory pathways is also underscored by an impressive list of
diseases found to be associated with abnormal miR expres-
sion. Evidence is accumulating that many age-related
diseases are associated with a decreased control of cell
signaling, DNA repair, oxidative stress responses, and
apoptosis.4-7 With signiﬁcant progress in miR microarray
technology, numerous sets of miRs have been found to
be highly or speciﬁcally expressed in aortic tissues with
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importance of miRs in human AAAs is still very scarce,
with, for example, only 14 studies identiﬁed when using
AAA and microRNA as keywords to search PubMed.
The present study aimed to analyze the miR expression
patterns of human vascular smooth muscle cells (VSMCs)
obtained from AAA explant cultures and to compare
them with control aortas using the highly sensitive and
speciﬁc miRCURY microarray platform. Altered expression
of individual miR was further validated by quantitative real-
time polymerase chain reaction (qPCR). If the biological
importance of miRs in the pathogenesis of AAAs can be
conﬁrmed, these results may lead to new therapeutic strat-
egies for AAA in the future.
METHODS
Human abdominal aorta tissue collection. Medial
sections of aneurysm wall samples, which were dissected
of luminal thrombus and adventitia, were acquired from
AAA patients who underwent open surgical aneurysmal
repair in a local hospital. Control aortic tissues from the cor-
responding location were obtained at liver transplantation
procurement. All liver donors had no known cardiovascular
diseases and connective tissue disorders. Aneurysmal
patients with Marfan syndrome or other connective tissue
disorders were excluded from this study. Each collected
specimen was thoroughly washed with Dulbecco’s modiﬁed
Eagle’s medium (DMEM) solution and cultured in DMEM
(Invitrogen, Carlsbad, Calif). The remaining specimens
were kept in a 80C freezer until protein analysis. All
experiments were performed with the approval from the
local institution’s ethics committee. Informed consent was
obtained from AAA patients and organ donors’ relatives.
Aortic organ explant cultures. Both aneurysmal and
normal aortic walls were washed free of blood and trans-
ported to a sterile tissue culture hood in DMEM (Invitro-
gen). The aortic tissues were divided into 1- to 2-mm2
segments of medial wall and were placed into six separate
wells of tissue culture plates, supplemented with 3 mL of
DMEM containing 10% heat-inactivated fetal bovine
serum, 2 mmol/L L-glutamine, 100 U/mL penicillin, and
100 mg/mL streptomycin. The plates were incubated at
37C in a humidiﬁed 5% CO2 atmosphere. After 4 to 7
days, before the cultured cells reached conﬂuence, the cells
were harvested for gene and protein study. Conditioned
media were collected and stored at 20C for secretory
cytokine detection using enzyme-linked immunosorbent
assay (ELISA). The homogeneity of VSMCs expressed in
the explant cultures was conﬁrmed by histochemical stain-
ing with anti-a-actin antibody (Cat. No. M0851; Dako,
Glostrup, Denmark).
Total RNA isolation. Total RNAs were isolated using
Trizol reagent (Invitrogen) and further puriﬁed using an
RNeasy mini kit (Qiagen, Valencia, Calif). RNA quality
control was performed using Bioanalyzer 2100 in Genome
Research Center, The University of Hong Kong. Puriﬁed
total RNAs (with good quality) were sent to Exiqon
(Vedbaek, Denmark) for miR expression analysis. MiRmicroarray analyses including labeling, hybridization, scan-
ning, and normalization were carried out by Exiqon.
miR proﬁling using miRCURY LNA microarray.
In brief, 500 ng of total RNA from each specimen was
labelled with an Hy3 and Hy5 ﬂuorescent label,
respectively, using the miRCURY locked nucleic acid
(LNA) array power labelling kit (Exiqon) following the
instructions from the manufacturer. Similarly, the Hy3-
labelled samples and an Hy5-labelled reference RNA
sample were mixed pair-wise and hybridized to the
miRCURY LNA array version ﬁfth generation (Exiqon),
which contains capture probes targeting all human miRs in
the miRBASE v.16.0 at the Sanger Institute (Cambridge,
UK). The hybridization was performed according to the
miRCURY LNA array manual using a Tecan HS4800
hybridization station (Tecan, Grödig, Austria). Three
independent hybridizations for each sample were per-
formed on chips with each miR spotted in quadruplicate.
Labeling efﬁciency was evaluated by analyzing the signals
from control spike-in capture probes. This set of LNA-
modiﬁed oligonucleotides was designed to have uniform
melting temperatures of 72C against their complementary
targets. After hybridization, the microarray slides were
scanned and stored in an ozone-free environment (ozone
level below 2.0 ppb) in order to prevent potential bleach-
ing of the ﬂuorescent dyes. The miRCURY LNA array
microarray slides were scanned using the Agilent G2565BA
Microarray Scanner System (Agilent Technologies, Inc,
Santa Clara, Calif), and image analysis was carried out using
the ImaGene 9.0 software (BioDiscovery, Inc, Hawthorne,
Calif). The quantiﬁed signals were background corrected
(Normexp with offset value 10) and normalized using
the global LOWESS (LOcally WEighted Scatterplot
Smoothing) regression algorithm. Fold changes in miR
expression levels from independent arrays were calculated
and presented as means. Putative targets of the miRs were
predicted using the online software MiRANDA.
qPCR for altered miR expression. The expression
levels of altered miRs and one reference gene were further
validated by qPCR using the miRCURY LNA microRNA
PCR system and SYBR Green master mix, following the
manufacturer’s instructions (Exiqon). qPCRwas performed
using an Applied Biosystems 7900 Sequence Detection
system (Applied Biosystems Inc, Foster City, Calif). Poten-
tial gene targets were retrieved from the miR target predic-
tion database, miRANDA. Three predicted targets that
were thought to be involved in inﬂammation and vascular
remodeling were selected for further expression analysis.
The expression levels of any differentially expressed
miRs detected in the Exiqon microarray platform were ﬁrst
validated in the corresponding samples using individual
real-time qPCR assays. Then, the qPCR assays were further
performed on explant cultures from an extra set of AAA
patients and control aortas for better understanding of
the characteristics of the differentially expressed miRs.
Quantiﬁcation of proinﬂammatory mediators using
ELISA. The secretory levels of cytokine interleukin (IL)-3
and vascular endothelial growth factor A (VEGFA), which
Table I. Characteristics of AAAs and control groups
AAA (n ¼ 6) Control (n ¼ 6)
Age, years 69.5 6 8.2 42.2 6 9.2
Males/females 6/0 6/0
Aneurysm diameter, cm 7.56 6 1.17 -
Hypertension 1 (16.7%) -
Smoking 5 (83.3%) -
AAA, Abdominal aortic aneurysm.
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regulated miR516a-5p, were detected in the culture media
by the Quantikine kit (R&D Systems, Abingdon, UK).
VSMCs collection and lysis for speciﬁc protein-
expression analysis. VSMCs were harvested and mixed
with lysis buffer (Cell Signaling Technology, Danvers,
Mass) containing protease inhibitor (Roche, Basel,
Switzerland) for protein-based assays. After centrifuga-
tion at 4C for 15 minutes at 13,000 rpm, the superna-
tants were collected and stored at 80C until use.
Western blot analysis of COL1A1. The protein
expression of collagen type 1, alpha 1 (COL1A1), one of
the target genes for the downregulated miR1260, was
analyzed in the VSMCs of aneurysmal explant cultures
and compared with that of normal aorta.
The protein concentration of each specimen was
measured based on the Bradford method, using the Bio-
Rad Protein Assay Kit (Bio-Rad Laboratories, Hercules,
Calif) with bovine serum albumin as the standard. After
denaturing the protein with loading buffer (pH 6.8
24 mM Tris-HCl, 684 mM glycerol, 14 mM SDS,
142 mM beta-mercaptoethanol, 0.3 mM bromophenol
blue), each sample (50 mg) was resolved on 12% SDS-
polyacrylamide gel electrophoresis gel (Bio-Rad Laborato-
ries) at room temperature and then transferred onto a
polyvinylidene ﬂuoride membrane (Bio-Rad Laboratories)
at 4C. Subsequently, each sample was blocked in 10%
TBSe0.01% Tween 20 diluting nonfatty milk (Bio-Rad
Laboratories) for 2 hours at room temperature. The
membranes were then incubated overnight at 4C with
primary antibodies against COL1A1 (catalogue no.
AF6220; R&D Systems, Abingdon, UK, 140 kDa) with
glyceraldehyde 3-phosphate dehydrogenase (GAPDH;
catalogue no. 2118, 1:10000 dilution; Cell Signaling Tech-
nology, 37 kDa) as positive control. After membrane
washing using TBST solution, HRP-conjugated secondary
antibody (Dako) was added, and the membranes were
then incubated for 1 hour at room temperature. After
washing, signals were visualized by luminol reagents (GE
Bio-Rad Laboratories) and the densitometry of each
exposing blotting was analyzed by ImageJ 1.44 software
(National Institutes of Health, Bethesda, Md). The relative
expression of the studied collagen protein was calculated by
the detected signal divided by the internal positive control
(GAPDH) expression signal in each sample.
Statistical analysis. Results are expressed as mean 6
standard deviation (SD). Comparisons between two
groups were made by Student t-test. P values of <.05 or
less were considered signiﬁcant.
RESULTS
Expression proﬁles of miRs in AAAs and normal
aortas with altered genes identiﬁed. Six male AAA
patients and six sex-matched organ donors with normal
aortas were recruited for this study. The demographic data
of the patients are summarized in Table I. The hybridiza-
tion signals of miR expression levels ranged from several
thousand to a few hundred units. Several expressionpatterns of miRs were found to be signiﬁcantly different
between these two groups. Only those genes that showed
good reproducibility and reliability and with alteration
tendency (P < .05 and fold change >2) were selected as
differentially expressed genes. A short summary list of
differentially expressed miRs is shown in Table II. Out of
all the miRs expressed on the array, only two miRs with
signiﬁcantly altered expression were identiﬁed. Compared
with normal aortic explants, an elevated miR-516a
expression and a reduced miR-1260 expression were
identiﬁed in the AAA explants, with the highest fold
change and statistical difference.
Conﬁrmation of array data using qPCR. qPCR on
the two identiﬁed miRs was ﬁrst performed in the corre-
sponding samples to verify the array results. The relative
fold changes in the expression of the miRs as detected by
qPCR assays validated the microarray results. The increase
of the expression of miR-516a-5p was more than threefold
and miR-1260 had an almost fourfold decrease, as vali-
dated by qPCR.
Additional qPCR analyses were performed on 10 AAA
samples (six elective AAAs and four ruptured AAAs) and 10
control aortas. All samples were male and comparable in
age (AAA patients’ mean age ¼ 62 6 12 years old, ﬁve
smokers; control organ donors’ mean age ¼ 59.66 6 years
old, eight nonsmokers, smoking histories of two organ
donors were missing). miR-1250a-5p was upregulated
fourfold in the AAA tissues compared with the control
samples, and miR-1260 was downregulated fourfold in
AAAs compared with control samples. The extra qPCR
results were consistent with the Exiqon results.
Among all of the AAA samples, no signiﬁcant differ-
ences in miR516a-5p or miR-1260 expression could be
detected between the aneurysm explant cultures from elec-
tive or emergency open operation. No signiﬁcant differ-
ences in the expression of these two speciﬁc miRs could
be detected in any of the control aortic samples. This
showed that the expression of miR516a-5p was not related
to the smoking habits of the AAA patients. Collectively, all
qPCR results (16 AAA samples and 16 control aortic
samples) conﬁrmed that the two differentially expressed
miRs were not age- or smoking-dependent and were
consistently expressed in the 16 AAA tissue samples or
the 16 control aortas.
Targets of miRs and functional annotations by
bioinformatics analysis. To further investigate the bio-
logical signiﬁcance of the expressed miRs, functional anno-
tations of the two miRs were analyzed by miRANDA
Table II. A summary of the miR proﬁling of AAA explants (n ¼ 6) vs control aortic explants (n ¼ 6) using miRCURY
LNA-based microarray platform (Exiqon)
Sample ID
Group
Average SD
dLMR SD Fold change
Probe ID Annotation P value A C A C A-C A-C A vs control
42550 hsa-miR-516a-5p .01 0.15 0.81 0.32 0.34 0.96 0.47 1.947
145975 hsa-miR-1260 .04 0.93 0.13 0.63 1.11 1.06 1.28 0.48
46755 hsa-miRPlus-E1026 .04 0.45 0.08 0.46 0.35 0.54 0.58 0.689
46498 hsa-miRPlus-F1099 .05 0.37 0.01 0.08 0.36 0.38 0.37 0.77
46624 hsa-miR-1236 .06 0.02 0.42 0.21 0.47 0.4 0.51 0.759
145838 hsa-miR-125b-1 .06 0.48 1 0.49 0.24 0.53 0.55 1.441
46786 hsa-miRPlus-F1193 .06 0.16 0.22 0.19 0.28 0.38 0.33 1.298
146196 hsa-miR-711 .07 0.46 0.95 0.32 0.26 0.49 0.41 1.403
11175 hsa-miR-525-5p .07 0.36 0.22 0.39 0.29 0.58 0.49 1.493
42661 hsa-miR-492 .07 0.28 0.68 0.28 0.17 0.39 0.33 1.311
46473 hsa-miRPlus-E1112 .1 0.21 0.12 0.24 0.22 0.33 0.33 1.257
46256 hsa-miRPlus-E1238 .11 0.33 1.09 0.54 0.58 0.76 0.79 1.691
17354 hsa-miR-637 .11 0.8 0.19 0.79 0.59 1 0.99 0.501
45891 hsa-miRPlus-E1285 .12 0.14 0.75 0.48 0.41 0.61 0.63 1.529
146072 hsa-miR-1469 .14 0.41 0.12 0.42 0.46 0.53 0.62 0.691
46885 hsa-miRPlus-E1225 .15 0.33 0.54 0.81 0.52 0.87 0.97 1.825
AAA, Abdominal aortic aneurysm; dLMR, absolute D LogMedianRatios; miR, microRNAs; SD, standard deviation.
Hsa-miR-516a-5p and mi-1260 showed the highest fold change (P < .05).
Table III. The most aortic-related genes associated with
the identiﬁed hsa-miR-516a-5p
Broad phenotypes Target gene
(ANCA)-associated vasculitis TNF
Abdominal aortic aneurysm MTHFR
Hypertension MTHFR
Arterial and venous thrombosis MTHFR
Arthritis TNF
Arthritis IL-3
Arthritis, juvenile TNF
Arthritis, psoriatic NFKB1
Arthritis, psoriatic TNF
Atherosclerosis, coronary VEGFA
Atherosclerosis, coronary PPP1R3A
Atherosclerosis, coronary GPX1
Atherosclerosis, coronary PTGS1
Atherosclerosis, coronary TNF
Atherosclerosis, coronary MTHFR
Atherosclerosis, coronary CXCL12
Atherosclerosis, generalized GPX1
Blood pressure FURIN
Blood pressure, arterial GNAS
CXCL 12, Chemokine (C-X-C motif) ligand 12; FURIN, furin; GNAS,
stimulatory G-protein alpha subunit; GPX1, glutathione peroxidase 1; IL-3,
interleukin-3; MTHFR, methylenetetrahydrofolate reductase; NFKB1,
nuclear factor NF-kappa-B p105 subunit 1; PPP1R3A, protein phosphatase 1
regulatory subunit 3A; PTGS1, prostaglandin-endoperoxide synthase 1;
TNF, tumor necrosis factor; VEGFA, vascular endothelial growth factor A.
Source: miRANDA bioinformatics analysis, total 756 entries. The secretory
protein levels encoded by the underlined genes e IL-3 and VEGFA e were
analyzed.
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involved in aortic stiffness, arterial wall changes, ath-
erosclerosis, inﬂammation, hypertension, cytokines, and
chemokine-dependent cell signaling. All these functions
are predicted pathways for AAA formation (Tables III
and IV).
Secretory level of IL-3 and VEGFA. IL-3 and
VEGFA, were detectable in the culture media of both types
of tissue cultures. The secretory levels were signiﬁcantly
increased in the aneurysmal explant cultures compared
with those of normal aortas (P < .05) (Table V).
COL1A1 in VSMCs. COL1A1 protein expression,
which is one of the predicted miR-1260 targets, was in-
creased in theVSMCsof the aneurysmaortic explant cultures
compared with those in the normal aortas (P < .05) (Fig).
DISCUSSION
Unlike conventional mRNA expression proﬁling, accu-
rate miR proﬁling is technically challenging due to the
small size of mature miRs and the sequence similarity be-
tween miR family members. In the present study, a distinct
miR expression proﬁle in the diseased human VSMCs was
generated using the new miR microarray technology with
high sensitivity and speciﬁcity.
The existing literature is very limited, and only 14 pub-
lished studies were foundonPubMedusing the search terms
of microRNA and aneurysm. In the extant research, miR-
143 and -145 were found to positively regulate vascular
smooth-muscle speciﬁc gene expression, differentiation,
actin cytoskeleton, and contractile function.8,9 miR27b
and miR-130a were found to be proangiogenic,10,11 and
miR-221/222 were found to be regulators for VSMC
proliferation and neointimal hyperplasia.12 The study by
Milewicz et al also found that decreasing levels of miR-
29b in the aortic wall can attenuate aortic aneurysmprogression in two different mouse models.13 These studies
highlighted the relevance of miRs in aortic disease. In addi-
tion, some studies indicated that miRs have distinct expres-
sion proﬁles and play crucial roles in various vascular
pathologic processes such as aging,14 remodeling, athero-
sclerosis, and inﬂammation.15,16 To the best of our
Table IV. The most aortic-related genes associated with
the identiﬁed hsa-miR-1260
Broad phenotypes Target gene
Angina GP1BA
Aortic stiffness CYP11B2
Aortic stiffness COL1A1
Arterial stiffness blood pressure, arterial ECE2
Arterial wall changes CYP11B2
Arthritis TAP2
Atherosclerosis, carotid AHSG
Atherosclerosis, coronary LMNA
Atherosclerosis, coronary PECAM1
Atherosclerosis, coronary CYP11B2
Atherosclerosis, coronary lipoprotein HAP1
Atherosclerosis, coronary myocardial infarct GP1BA
Atherosclerosis, diabetes PTPN1
Atherosclerosis, generalized GP1BA
AHSG, Alpha-2-HS-glycoprotein; COL1A1, collagen, type I, alpha 1;
CYP11B2, cytochrome P450, family 11, subfamily B, polypeptide 2; ECE2,
endothelin converting enzyme 2; GP1BA, glycoprotein Ib (platelet), alpha
polypeptide; HAP1, Huntingtin-associated protein 1; LMNA, lamin A/C;
PECAM1, platelet endothelial cell adhesion molecule 1; PTPN1, protein
tyrosine phosphatase, non-receptor type 1; TAP2, protein antigen peptide
transporter 2.
Source: miRANDA bioinformatics analysis, total 774 entries. The expres-
sion of speciﬁc protein COL1A1 encoded by the underlined gene was
analyzed.
Table V. The secretory levels of IL-3 and VEGFA in
the culture media of control aortas explant cultures and
AAA explant cultures
IL-3 VEGFA
Control aortas 60 6 15 125 6 52
AAA specimens 350 6 60a 452 6 80a
AAA, Abdominal aortic aneurysm; IL, interleukin; VEGFA, vascular
endothelial growth factor A.
aP < .05.
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results with functional annotations of the involvement of
miRs in the explant cultures of clinical AAA samples. The
available literature includes three recent miR studies on
aneurysm walls. However, the specimens used were either
full-thickness aneurysmal wall that are heterogeneous in
terms of the cellular composition17 or taken from animal
models.18,19 Pahl et al revealed that three miRs (miR-21,
-146a, 181a) were upregulated in AAA surgical samples,
while ﬁve miRs (miR-30c-2, -133a, -133b, -204, -331-3p)
were signiﬁcantly downregulated.17 In the study by Liu
et al, 10 mouse miRs (miR-19a, -19b, 34b, -92a, -132,
-142-3p, -149a, -188, -221, -222) were upregulated and
ﬁve (148b-39, 152, -181a, -301a, -497) were downregu-
lated.18 Another animalmodel found that AAAdevelopment
was accompanied by decreased aortic expression ofmiR-29b,
along with increased expression of known miR-29b targets,
COL1A1 (which aligns with our results), COL3A1,
COL5A1, and Eln.19 In addition, theMaegdefessel research
group tried to manipulate miR-29b and study the speciﬁceffect onmurine abdominal aortic aneurysm development.19
Interestingly, there were no common miRs found among
the previous human or experimental AAA studies and also
our explant cultures study. Milewicz collectively conferred
the important role of miR-29 in aortic remodeling that
probably involved in aneurysm formation.13 However,
miR-29 was not differentially expressed in our samples.
Speciﬁcally, the present miR expression platform
proﬁles of all aortic samples were based on miRBASE 16
scanning for 1205 potential human miR target sequences.
Another newly released human AAA study employed Affy-
metrix GeneChip miRNA 1.0 Array (Santa Clara, Calif),
which contained 847 miR probes. Thus, the discrepancy
of our results may be due to the different miR sources and
also different miR expression platforms used in our study.
Identical results were found between intact and
ruptured AAAs. Thus, these two speciﬁc miRs may not
be markers for rupture predication. Collectively, all qPCR
results (16 AAA samples and 16 control aortic samples)
conﬁrmed that the two differentially expressed miRs were
not age or smoking dependent and were consistently
expressed in AAA tissue or control aortas.
The putative targets of the two differentially expressed
miRs were annotated by miRANDA bioinformatics. The
numerous target genes predicted are mainly involved in
aortic stiffness, arterial wall changes, atherosclerosis, in-
ﬂammation, hypertension, cytokines, and chemokine-
dependent cell signaling. These pathways are all involved
in AAA formation.20
To understand the functional signiﬁcance of the two
identiﬁed miRs, validation of some interested predicted
targets was performed. The expression of two proinﬂamma-
tory mediators, namely IL-3 and VEGFAdwhich were the
predicted targets of the upregulated miR516p-5adand
COL1A1dwhich was the predicted target of the downre-
gulated miR1260dwere examined accordingly. These
three predicted targets were upregulated in the AAA
explants compared with that in the control aortic specimens.
The detectable targets in the culture cells may partially
conﬁrm the potential involvement of the two identiﬁed
miRs in AAA pathogenesis.
First, the secretion of proinﬂammatory mediator IL-3,
which is one of the predicted targets of the upregulated
miR-516a-5p, was enhanced in the AAA explants. To
date, IL-3’s involvement in aneurysmal formation remains
unknown, although many other cytokines, including inter-
leukins IL-1, -2, -6, and -8, are thought to be important
mediators for aneurysmal growth.21 Interestingly, a
research group found that IL-3 is frequently elevated in
patients suffering from coronary arterial disease. Multivar-
iate analysis showed that IL-3 concentration was the only
independent parameter predicting symptomatic restenosis
in patients undergoing percutaneous coronary interven-
tion.22 Previous studies also suggested that IL-3 plays
a role in the pathophysiology of atherosclerosis. In human
umbilical vein endothelial cells, IL-3 can stimulate the
expression of P-selectin, a proatherogenic adhesion mole-
cule that mediates rolling, adhesion, and transmigration
Fig. Upper panel, Representative Western blot results of collagen type 1, alpha 1 (COL1A1) protein expression in
control aortas (control 1-6) and AAA specimens (AAA 1-6). COL1A1 protein was detectable in all control aortas and
AAA specimens, in which the expression is signiﬁcantly increased in AAAs compared with control aortas. Lower panel,
Relative intensities of COL1A1 protein in control aortas and AAAs. COL1A1 protein levels were signiﬁcantly upre-
gulated compared with control aortic tissues (P < .05). GAPDH, Glyceraldehyde 3-phosphate dehydrogenase.
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found to stimulate endothelial cell motility and promote
in vivo new vessel formation.25 Taken together, there is
accumulating evidence suggesting that IL-3 is a relevant
factor in the progression of the atherosclerosis that may
be involved in AAA formation.
Second, the secretory levels of VEGFA, another pre-
dicted target of the miR-516-5p, were more increased in
the AAA explant cultures than in the control aortas.
Indeed, VEGFA is a member of the platelet-derived
growth factor (PDGF)/vascular endothelial growth factor
(VEGF) family. This protein acts speciﬁcally on endothelial
cells, leading to such effects as increasing vascular perme-
ability, inducing angiogenesis, vasculogenesis and endothe-
lial cell growth, promoting cell migration, and inhibiting
apoptosis. Alternatively spliced transcript variants, namely
VEGFA, -B, and -C, have been characterized.26 Recently,
a Japanese research group showed an increased VEGFA
levels in human AAAs and experimental mice AAAs.27
Another recent study found a highly signiﬁcant correlation
between VEGFA and metalloproteinase (MMP)-2 in the
progression of gastric cancer.28 In addition, VEGF and
MMP-9 might act synergistically to positively regulate
angiogenesis.29 MMP-2 and MMP-9 are the main metallo-
proteinases to degrade matrix protein and play a critical
role in atherosclerosis and the pathogenesis of aneurysms.20
Thus, the expression of these two downstream targets of
the differentially expressed miR-516p further conﬁrms
the importance of miR516-5p and is particularly essential
to the understanding of the cellular regulatory networks
of matrix-degraded aneurysms.
Third, COL1A1 protein expression was found to be
upregulated in aneurysms and consistent with the results
of the study of Maefdefessel et al.19 Indeed, type I collagen
is the predominant ﬁber in the aortic wall that provides
tissues with tensile strength and is believed to impart arte-
rial stiffness. Wang et al hypothesized that high collagencontent resulted in decreased arterial distensibility and
increased susceptibility to aortic dissection.30 To achieve
the highly variable levels of type I collagen in different
tissues during development, growth, aging, and tissue
repair, the genes encoding the constituent a1 and a2
chains of type I collagen, COL1A1 and COL1A2 are
likely to be under complex transcriptional and post-
transcriptional control.31 These elements were also found
to mediate the complex effects of cytokines.32
Taken together, the two proinﬂammatory mediators
may participate in the inﬂammatory and atherosclerotic
processes in AAA formation, and the increased COL1A1
may be somehow mediated by cytokines, which is impor-
tant for matrix remodeling in the aorta that ultimately led
to aneurysm formation. Any correlation between the
COL1A1 and cytokines deﬁnitely needs to be further
investigated. However, miRs mostly mediate translational
repression or degradation of the mRNAs, resulting in
downregulation of the protein level and also the ability to
stimulate gene expression. Therefore, the expression of
these two downstream targets of the differentially
expressed miR-516p may be negatively regulated by the
intermediate cellular regulatory networks of the matrix-
degraded aneurysm, but the underlying mechanism for
the increased expression of the three downstream target
genes remains unresolved.
Most recent miR studies focus on miR-29 in
AAAs.14,19,33 Those studies postulate that miR-29 is
involved in aneurysm formation by post-transcriptionally
repressing the expression of extracellular matrix proteins.
Indeed, miR-29 targets several extracellular matrix proteins,
which are known to maintain the integrity of the vascular
wall.14 MiR-29 was additionally shown to induce apoptosis
in cancer cells by targeting myeloid cell leukemia sequence 1,
an antiapoptotic B-cell lymphoma 2 family member.6
Smooth muscle cell apoptosis is considered to favor aneu-
rysm formation,1 and this mechanism may contribute to
JOURNAL OF VASCULAR SURGERY
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Thus, therapeutic inhibition of miR-29 using anti-miRs is
suggested to be a novel therapeutic approach to interfere
with vascular aging by augmenting matrix synthesis.
Although the precise function of the presently detected
miRs remains to be determined, our results may supple-
ment the study of miR expression in AAAs.
One limitation of our study is that only samples from
late stages of the human aneurysmal disease can be ob-
tained from surgical intervention for this differential micro-
RNA study. Most miRs are studied in experimental
aneurysm models, which may account for the different
miR expressions in different studies. However, our results
may further consolidate the importance of miRs in the
AAA pathogenesis.
In conclusion, increased miR-516-5p expression and
decreased miR-1260 expression with the corresponding
target expressions were observed in human AAA explant
cultures compared with control aortas. Given the emerging
role of miRs in physiological events and diseases, these two
miRs may be crucial in AAA pathogenesis. The administra-
tion of anti- and overexpression of the two miRs in vivo
using a lentiviral vector is currently under investigation in
our laboratory to delineate the importance of the detected
miRs and the involved pathways in the pathogenesis of
AAAs. The present investigation can support the thera-
peutic manipulation of miRs and their target genes for
limiting AAA disease progression.
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